Cargando…
Partial splenic embolization to permit continuation of systemic chemotherapy
Systemic chemotherapy treatments, commonly those that comprise oxaliplatin, have been linked to the appearance of distinctive liver lesions that evolves to portal hypertension, spleen enlargement, platelets sequestration, and thrombocytopenia. This outcome can interrupt treatment or force dosage red...
Autores principales: | Luz, Jose Hugo M., Luz, Paula M., Marchiori, Edson, Rodrigues, Leonardo A., Gouveia, Hugo R., Martin, Henrique S., Faria, Igor M., Souza, Roberto R., Gil, Roberto de Almeida, Palladino, Alexandre de M., Pimenta, Karina B., de Souza, Henrique S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5083724/ https://www.ncbi.nlm.nih.gov/pubmed/27611010 http://dx.doi.org/10.1002/cam4.856 |
Ejemplares similares
-
Portal vein embolization with n-butyl-cyanoacrylate through an ipsilateral approach before major hepatectomy: single center analysis of 50 consecutive patients
por: Luz, José Hugo Mendes, et al.
Publicado: (2017) -
Partial splenic embolization for refractory thrombocytopenia
por: Best, Irwin M.
Publicado: (2011) -
Clinical Application of Partial Splenic Embolization
por: Guan, Yong-Song, et al.
Publicado: (2014) -
Quantitative splenic embolization possible: application of 8Spheres conformal microspheres in partial splenic embolization (PSE)
por: Lu, Haohao, et al.
Publicado: (2021) -
DEB TACE for Intermediate and advanced HCC – Initial Experience in a Brazilian Cancer Center
por: Luz, Jose Hugo Mendes, et al.
Publicado: (2017)